Nemera’s Safelia TM autoinjector platform has been designed as a new injection paradigm to respond to the challenge of handling new formulations taking patients into consideration.

SafeliaTM autoinjector :

• administers a large range of formulations and injection volumes; the platform can adapt by design to handle liquid injections to highly viscous formulations, taking care specifically of biologics, sustain released formulations and shier sensitive molecules up to 2,25ml injection volumes

• improves patient experience, with the possibility to reduce needle Gauge, reduce injection time, slowing down the needle penetration inside the body tissues and gives the possibility of a delayed retraction for viscous injections especially.